LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC

Clinical trial NCT02494921 · COMPLETED

Trial details

NCT number: NCT02494921
Sponsor: Rahul Aggarwal
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2015-11-20
Primary completion: 2021-07-30
Enrollment: 43

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.